Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.57 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 6/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.50 |
| ▸ | NPC1 | O15118 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | PTPRA | P18433 | 1/20 | 0.49 |
| ▸ | PTPRB | P23467 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29355385 | 1.00 | TSHR (0.57) | TSHRHPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL305525 | 1.00 | TSHR (0.57) | TSHRHPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11023727 | 0.90 | CYP1A2 (0.59) | TSHRHPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL30124927 | 0.90 | CYP1A2 (0.59) | TSHRHPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11023723 | 0.90 | CYP1A2 (0.59) | TSHRHPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11850429 | 0.89 | CYP1A2 (0.58) | TSHRHPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11850418 | 0.89 | CYP1A2 (0.58) | TSHRHPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL11850423 | 0.89 | CYP1A2 (0.58) | TSHRHPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL7113087 | 0.89 | HPGD (0.57) | TSHRHPGDCYP1A2CYP2C9CYP2C19 | |
| SCHEMBL7113084 | 0.89 | HPGD (0.57) | TSHRHPGDCYP1A2CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140170591-A1 | DENTAL ARCH MODEL AND METHOD OF MAKING THE SAME | GLOBAL FILTRATION SYSTEMS, A DBA OF GULF FILTRATION SYSTEMS INC. (US) | 2014-06-19 | — | — | US | claimed |
| US-8092963-B2 | Toner compositions | XEROX CORPORATION (US) | 2012-01-10 | — | — | US | claimed |
| US-9539072-B2 | Method of making a dental arch model | GLOBAL FILTRATION SYSTEMS (US) | 2017-01-10 | — | — | US | disclosed |
| US-9504637-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-9504637-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160106648-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. (US) | 2016-04-21 | — | — | US | disclosed |
| US-20160106648-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. (US) | 2016-04-21 | — | — | US | disclosed |
| US-9248086-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-9248086-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-20150174026-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. | 2015-06-25 | — | — | US | disclosed |
| US-20150174026-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. | 2015-06-25 | — | — | US | disclosed |
| WO-2008102019-A2 | USE OF WATER-DISPERSIBLE CAROTINOID NANOPARTICLES AS TASTE MODULATORS, TASTE MODULATORS CONTAINING WATER-DISPERSIBLE CAROTINOID NANOPARTICLES, AND METHOD FOR TASTE MODULATION | BASF SE (DE) | 2008-08-28 | — | — | WO | disclosed |
| WO-2008102018-A2 | METHOD FOR MODULATING THE TASTE OF MATERIAL COMPISITIONS CONTAINING AT LEAST ONE HIGH INTENSITY SWEETENER (HIS) | BASF SE (DE) | 2008-08-28 | — | — | WO | disclosed |
| US-7306632-B2 | Leave-in color conditioner | HAIRMARKER LLC (US) | 2007-12-11 | — | — | US | disclosed |
| US-20070226919-A1 | Method for Dyeing or Printing Textile Materials | HUNTSMAN INTERNATIONAL LLC (US) | 2007-10-04 | — | — | US | disclosed |
| US-20070226919-A1 | Method for Dyeing or Printing Textile Materials | HUNTSMAN INTERNATIONAL LLC (US) | 2007-10-04 | — | — | US | disclosed |
| US-20050198746-A1 | Leave-in color conditioner | HAIRMARKER LLC | 2005-09-15 | — | — | US | disclosed |
| US-20050028895-A1 | Radiation curable precious metal preparation, transfers containing same and method for decoration | FERRO GMBH (DE) | 2005-02-10 | — | — | US | disclosed |
| EP-1291335-B1 | Radiation curable precious metal composition, decalcomanias containing it and method of decorating | FERRO GMBH (DE) | 2004-08-11 | — | — | EP | disclosed |
| EP-1291335-A1 | Radiation curable precious metal composition, decalcomanias containing it and method of decorating | OMG AG & Co. KG (DE) | 2003-03-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160106648-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | TSHR 4752/4885HPGD 738/4885CYP1A2 1159/4885 |
| US-20150174026-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | TSHR 4752/4885HPGD 738/4885CYP1A2 1159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.